X
Xenetic Biosciences, Inc. (XBIO)
NCM – Real vaqt narxi. Valyuta: USD
3.02
-0.12 (-3.68%)
Yopilishda: May 12, 2026, 4:00 PM EDT
3.07
+0.05 (1.50%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.02
-0.12 (-3.68%)
Yopilishda: May 12, 2026, 4:00 PM EDT
3.07
+0.05 (1.50%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Xenetic Biosciences, Inc., biotexnologik kompaniya, saratonni davolash uchun immunoonkologiya texnologiyalarini ishlab chiqishga qaratilgan. Uning DNaz texnologiyasi saratonning o'sishi, metastazlanishi va rivojlanishida ishtirok etadigan va immunoterapiya, kimyoterapiya va radioterapiyaga chidamliligini oshiradigan neytrofil hujayradan tashqari tuzoqlarga (NETS) qaratilgan. Kompaniyaning mahsulot qatori oshqozon osti bezi rakini va qattiq o'smalarni davolash uchun XBIO-015; qattiq o'smalarni davolash uchun XBIO-020; va surunkali buyrak kasalligi (CKD) bo'lgan bemorlarda kamqonlikni davolash uchun PolyXen platformasi texnologiyasidan foydalanadigan ErepoXenni o'z ichiga oladi. U Takeda Pharmaceutical Co. Ltd bilan sub-litsenzion kelishuvga ega, shuningdek, Serum Institute of India, PJSC Pharmsynthez va SynBio, LLC bilan turli tadqiqot, ishlab chiqish, litsenziya va ta'minot shartnomalariga ega. Xenetic Biosciences, Inc. shtab-kvartirasi Framingham, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. James F. Parslow | CFO, COO, Interim CEO & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-24 | 8-K | xenetic_8k.htm |
| 2026-04-24 | 10-K/A | xenetic_10ka1-123125.htm |
| 2026-03-13 | 8-K | xenetic_8k.htm |
| 2026-03-12 | 10-K | xenetic_i10k-123125.htm |
| 2026-01-09 | 8-K | xenetic_8k.htm |
| 2025-12-11 | 8-K | xenetic_8k.htm |
| 2025-11-13 | 8-K | xenetic_8k.htm |
| 2025-11-12 | 10-Q | xenetic_i10q-093025.htm |
| 2025-10-31 | DEF 14A | xenetic_idef14a.htm |
| 2025-08-13 | 8-K | xenetic_8k.htm |